In another signal of the appetite among investors for companies applying artificial intelligence to drug discovery, Pathos AI has gathered an impressive $365 million in fourth-round financing as it ...

From infomercials to political canvassing to appeals for coveted roles, the most compelling rhetoric uses a mix of ethos, pathos, and logos. These techniques encompass a wide spectrum of human ...

2K Games has poached Apex Legends producer Ben Brinkman from Respawn to head up the team at 31st Union, which is developing 2K's upcoming third-person roguelike extraction-shooter, Project Ethos. On ...

GameSpot may get a commission from retail offers. 2K Games hasn't said much about its free-to-play third-person shooter currently in the works under the working title Project Ethos, but the game is ...

Defense Secretary Pete Hegseth is convening hundreds of high-ranking officers on short notice for a meeting in Virginia on Tuesday to give a speech on his views of the “warrior ethos” amid his ...

Sept 26 (Reuters) - Ethos Technologies recorded a 55% jump in revenue in the first half of 2025, according to its U.S. initial public offering paperwork filed on Friday, as the insurance IPO market ...

Defense Secretary Pete Hegseth has ordered hundreds of generals to Virginia next week to discuss grooming, standards and his “warrior ethos” vision — an unusual move that has sparked confusion among ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Pathos AI, the biotech drug developer spun out of Tempus ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief ...

Tempus AI Inc. (NASDAQ:TEM) during the first quarter secured a multi-million dollar deal to build “the world’s largest foundation model for oncology.” “And this is big for a few reasons,” said Tempus ...